James E. Levine has not been actively trading shares of Cardiff Oncology within the last three months. Most recently, on Friday, September 16th, James E. Levine bought 30,000 shares of Cardiff Oncology stock. The stock was acquired at an average cost of $1.56 per share, with a total value of $46,800.00. Following the completion of the transaction, the chief financial officer now directly owns 60,000 shares of the company's stock, valued at $93,600. Learn More on James E. Levine's trading history.